health 42

Regulatory oversight of those claims, announced in May, brings all tobacco products, including liquids used in vaporizers and e-cigarettes, under the same government oversight. All products must now carry warnings they contain nicotine, which is addictive. Sales of e-cigarette products are rising about 25 percent a year. Now that electronic devices fall under the Family Smoking Prevention and Tobacco Control Act, manufacturers will have to submit applications to the FDA, which must review and authorize health-related claims. But researchers from The Ohio State University say that prior to this new regulation, many unproven health claims have been circulating and that misinformation could have a lingering effect on consumers. And they emphasize the importance of the FDA now working consistently to prevent unapproved health claims. "The FDA can and should take action to ensure that inaccurate and misleading claims are discontinued," they wrote in the study, which app...

Researchers discovered that not only does LDN cause cancer cells to stop growing, it also alters their internal machinery, making them more likely to kill themselves. This can lead to other treatments becoming more effective. The research team, led by Dr Wai Liu and Professor Angus Dalgleish and working with the company LDN Pharma, discovered that the drug, when used in these small doses, can alter the genes that regulate how a cancer cell behaves. LDN can reactivate genes that promote cell killing, as well as modify the genes that interact with the immune system to make it more unfriendly to cancer. Dr Liu said: "We have shown that the genetic fingerprint of naltrexone differs according to the different doses used, which identifies new ways of using it as an anti-cancer treatment. "Rather than stopping the cancer cells from growing, patients want to be rid of them. We saw that by giving the drug for two days, then withdrawing it, cancer cells would stop cycling and u...

A study led by Dr Michael Livingston of Australia's Centre for Alcohol Policy Research at La Trobe University analysed the drinking habits of 124,440 Australians aged 14 to 79 years, surveyed over 18 years. The results show that recent declines in per-capita consumption appear to be driven by two major changes: (1) the aging of heavier drinking cohorts into lighter drinking stages of the life-course and (2) sharp reductions in drinking among recently born cohorts . Alcohol consumption among Australians peaks in middle-age, between 40 and 60 years. As drinkers move into their 60s and 70s, they tend to ease up, a trend that helps to explain the recent decline in drinking. But the main driver of reduced drinking in Australia is the markedly less drinking among Australians born in the 1990s, suggesting that a significant generational shift is underway. This shift has the potential to create long-term public health gains, given the body of research showing that the drinking pat...

A new psychology study conducted at Florida Atlantic University is the first to delve into the specific subcomponents of inhibition behavior as it relates to binge drinking to help predict who may be at high risk, and to better develop targeted education, intervention, and support programs. "There are many aspects of inhibition behavior, which is essentially the ability to stop yourself from a particular behavior," said Andres L. Paz, lead author of the study and a psychology student in FAU's Charles E. Schmidt College of Science who will be receiving his Ph.D. in August. "Looking specifically at risk factors, I wanted to see if there was one particular aspect of inhibition that could better predict propensity in young adults to binge drink." Previous studies on binge drinking have used a blanket approach on inhibition to gauge behavior. Over the course of one month, Paz investigated three specific subcomponents of inhibition behavior: the ability to stop ...